The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Nudelman Phillip M Phd since 2008.
The trader's CIK number is 1041084.
At the time of the last reporting, Nudelman Phillip M Phd was the Director of Cti Biopharma Corp. (stock ticker symbol CTIC).
Also see all insider trading activities at Cti Biopharma Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | CTIC | 0 | $0 | 0 | $0 | 39,698 | $0 |
| 2015 | CTIC | 0 | $0 | 150,000 | $217,514 | 0 | $0 |
| 2014 | CTIC | 0 | $0 | 100,000 | $356,100 | 0 | $0 |
| 2013 | CTIC | 0 | $0 | 200,000 | $248,879 | 0 | $0 |
| 2012 | CTIC | 0 | $0 | 200,000 | $115,999 | 0 | $0 |
| 2011 | CTIC | 0 | $0 | 120,000 | $40,480 | 0 | $0 |
| 2010 | CTIC | 0 | $0 | 320,000 | $129,880 | 0 | $0 |
| 2009 | CTIC | 0 | $0 | 164,000 | $257,480 | 0 | $0 |
| 2008 | CTIC | 25,000 | $14,249 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-04-29 | CTIC | Option Ex | 39,698 | .00 | 0 |
| 2015-09-29 | CTIC | Sale | 14,380 | 1.45 | 20,865 |
| 2015-09-30 | CTIC | Sale | 135,620 | 1.45 | 196,649 |
| 2014-03-25 | CTIC | Sale | 100,000 | 3.56 | 356,100 |
| 2013-08-06 | CTIC | Sale | 50,000 | 1.09 | 54,550 |
| 2013-03-08 | CTIC | Sale | 103,900 | 1.29 | 134,031 |
| 2013-03-07 | CTIC | Sale | 46,100 | 1.31 | 60,298 |
| 2012-06-29 | CTIC | Sale | 200,000 | .58 | 115,999 |
| 2011-02-28 | CTIC | Sale | 40,000 | .29 | 11,640 |
| 2011-01-31 | CTIC | Sale | 40,000 | .35 | 14,160 |
| 2010-12-31 | CTIC | Sale | 40,000 | .37 | 14,680 |
| 2010-11-30 | CTIC | Sale | 40,000 | .35 | 14,120 |
| 2010-10-29 | CTIC | Sale | 40,000 | .38 | 15,120 |
| 2010-09-30 | CTIC | Sale | 40,000 | .38 | 15,320 |
| 2010-08-31 | CTIC | Sale | 40,000 | .36 | 14,520 |
| 2010-07-30 | CTIC | Sale | 40,000 | .40 | 15,800 |
| 2010-06-30 | CTIC | Sale | 40,000 | .39 | 15,480 |
| 2010-05-28 | CTIC | Sale | 40,000 | .39 | 15,560 |
| 2010-05-03 | CTIC | Sale | 40,000 | .60 | 23,960 |
| 2009-08-14 | CTIC | Sale | 164,000 | 1.57 | 257,480 |
| 2008-03-18 | CTIC | Buy | 25,000 | .57 | 14,249 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nudelman Phillip M Phd (Director of Cti Biopharma Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.